CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Thai health officials said Tuesday that the government would consider an offer by U.S. drugmaker Abbott Laboratories to supply Thailand, and other countries, with its AIDS-fighting drugs at a discounted price.
Abbott earlier Tuesday announced that after consulting with the U.N.'s World Health Organization, it had decided to offer its drug Kaletra, also marketed under the name Aluvia, at a reduced price in the developing world.
''The company today offered to lower its price for its AIDS drug Kaletra from $181 per patient per month to $107 per patient per month, which could end up being cheaper than its generic version,'' Siriwat Tiptaradol, secretary-general of Thailand's Food and Drug Administration, was quoted saying in a news release from his agency.
The offer appeared to be a breakthrough in ending a dispute between Thailand and Abbott over the high price of Kaletra, which comprises the pharmaceutical ingredients lopinavir and ritonavir.
Thailand earlier this year announced it was breaking the patent on Kaletra so it could provide cheaper generic versions of the drug to those in need.
Abbott responded by declaring it would not introduce any new drugs in Thailand because the country failed to honor its intellectual property rights. An Abbott spokeswoman, Melissa Brotz, said Tuesday that policy has not changed.
Thailand's position drew much criticism from the local and foreign business community, while Abbott's action drew a firestorm of protest from health activists.
Siriwat said that the FDA will forward the Illinois-based company's offer to the Public Health Ministry for further deliberation.
The ministry in January issued ''compulsory licenses'' allowing the use of much cheaper generic versions of Kaletra, as well as the blood thinner Plavix, marketed by France's Sanofi-Aventis SA and U.S. drugmaker Bristol-Myers Squibb Co.
According to World Trade Organization agreements on intellectual property, a government may issue a compulsory license in case of a national public health emergency. Such action has been taken by several countries, most notably Brazil and India, especially for AIDS medicines.
A news release from Abbott said the company will offer its AIDS drugs to NGOs and governments of more than 40 low- and low-middle-income countries at a price of $1,000 per patient per year.
''This price is lower than any generic price available in the world today for this medicine and is approximately 55% less than the average current price for these countries,'' it said, adding that Thailand is one of the countries being offered the discount.
''Abbott did not say that they wanted us to revoke the compulsory license. There was no condition. They were just here to offer the price reduction so that people can have access to their medicines,'' Dr. Suchart Chongprasert, another Thai FDA official, told the Associated Press.
''We want to thank the company for their understanding of our position and the offer that they made, which will benefit Thai patients,'' he said.
Abbott's statement said the company was acting ''to further increase access and address the debate around pricing of HIV medicines: by increasing affordability while preserving the system that enables the discovery of new medicines.''
The World Heath Organization said it welcomed Abbott's pricing decision, and that it would work with all concerned parties ''to find mechanisms that address the immediate need to rapidly increase access and affordability of lifesaving drugs, while maintaining the long-term need to foster research and development in innovative medicines.'' (AP)
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Here Are Our 2024 Election Predictions. Will They Come True?
November 07 2023 1:46 PM
17 Celebs Who Are Out & Proud of Their Trans & Nonbinary Kids
November 30 2023 10:41 AM
Here Are the 15 Most LGBTQ-Friendly Cities in the U.S.
November 01 2023 5:09 PM
Which State Is the Queerest? These Are the States With the Most LGBTQ+ People
December 11 2023 10:00 AM
These 27 Senate Hearing Room Gay Sex Jokes Are Truly Exquisite
December 17 2023 3:33 PM
10 Cheeky and Homoerotic Photos From Bob Mizer's Nude Films
November 18 2023 10:05 PM
30 Steamy Photos of Folsom Street Fair 2023 Debauchery
October 15 2023 11:06 PM
42 Flaming Hot Photos From 2024's Australian Firefighters Calendar
November 10 2023 6:08 PM
These Are the 5 States With the Smallest Percentage of LGBTQ+ People
December 13 2023 9:15 AM
60 Burly Pics from Bearrison Street Fair 2022
October 08 2023 8:30 PM
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
Prince William's aversion to spectacle created one — and might spawn a King Harry
March 22 2024 6:24 PM
Outrage after Oklahoma prosecutor declines charges in Nex Benedict bullying death
March 22 2024 5:21 PM
George Santos leaves Republican Party, will run for House seat as independent
March 22 2024 4:07 PM
Catherine, Princess of Wales, announces she has cancer
March 22 2024 2:57 PM
Pride
Yahoo FeedProhibition Wellness & revolutionizing self-care for all
March 22 2024 1:19 PM
Tennessee bill would permit anti-LGBTQ+ foster and adoptee parents
March 22 2024 11:54 AM
Plus
Yahoo Feed8 dating tips for gay men from a gay psychotherapist
March 22 2024 11:51 AM
Trans woman assailed during Kanye West's Rolling Loud set beats back 'bullies' (exclusive)
March 22 2024 11:34 AM